Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_assertion type Assertion NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_head.
- NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_assertion description "[Various doses of I-131 (75, 300, 600, 1,200, and 2,400 microCi/5 mL) were incubated with hNIS-expressing colon cancer (CT26/hNIS) and parental cells (CT26), and numbers of MHC class I and Fas-expressing cells were determined by fluorescence-activated cell sorting (FACS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_provenance.
- NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_assertion evidence source_evidence_literature NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_provenance.
- NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_assertion SIO_000772 20053774 NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_provenance.
- NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_assertion wasDerivedFrom befree-2016 NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_provenance.
- NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_assertion wasGeneratedBy ECO_0000203 NP785320.RAlpVJ5GUI-0m4Jhxu0-mM41TO9GwsPLHhOJkl3hUoh1E130_provenance.